 NEW HAVEN, Conn., March 09, 2022 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. Nasdaq: BTAI, a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, will present at the upcoming Barclays Global Healthcare Conference on Tuesday, March 15 at 3:50 p.m. ET. Dr. Mehta will highlight the Companys neuroscience and immuno-oncology programs, artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process, and its commercial and launch readiness plans for its product candidate, BXCL501. 